Article
Pharmacological Therapy Determines the Gut Microbiota Modulation by a Pomegranate Extract Nutraceutical in Metabolic Syndrome: A Randomized Clinical Trial.
Molecular nutrition & food research - 1 Mar 2021
Cortés-Martín Adrián, Iglesias-Aguirre Carlos Eduardo, Meoro Amparo, Selma María Victoria, Espín Juan Carlos
Abstract excerpt
SCOPE: Poly-pharmacological therapy shapes the gut microbiota (GM) in metabolic syndrome (MetS) patients. The effects of polyphenols in poly-medicated MetS patients are unknown. METHODS AND RESULTS: A randomized, placebo-controlled, double-blinded, and crossover trial in poly-medicated MetS patients (n=50) explored whether the effects of a pomegranate extract nutraceutical (PE, 320 mg phenolics/day for 1 month)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
